News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

INFORMS Applauds Passage of Historic Legislation to Modernize STEM Education
News Release

BALTIMORE, MD, September 26, 2024 – In overwhelming bipartisan fashion, the U.S. House of Representatives just passed the “Mathematical and Statistical Modeling Education Act,” (H.R. 1735) which, if enacted, would modernize STEM education in the United States. The bill passed by unanimous consent.

Read More
Closing the Racial Gap in CRC: Screening is Just the First Step
Media Coverage

Too many people in the United States are dying of colorectal cancer (CRC). The #2 cancer killer in the United States, it impacts Black Americans disproportionately. Compared to White adults, Black adults aged 50 and above get colon cancer at a rate that’s 23% higher than White adults and have a 31% higher risk of dying from the disease.1 These disparities persist despite progress in screening and treatment and are particularly frustrating because CRC is highly treatable when caught in early stages and even preventable when pre-cancers are identified and removed through screening. These differences in incidence and mortality persist even while we have made progress to make screening more accessible to all. A 2019 NIH study showed that a similar proportion of Black and White Americans are up to date with CRC screening2, a meaningful improvement since 20053. If screening access and uptake are now so similar, why do these disparities persist?  

Read More
Big Government and Big Tech both want your biometric data
Media Coverage

Both Amazon and the Transportation Security Administration (TSA) are demanding the biometric data of all Americans.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
How Will You Be Told When It's Your Turn for a COVID-19 Vaccine? It's Complicated

How Will You Be Told When It's Your Turn for a COVID-19 Vaccine? It's Complicated

USA Today, December 24, 2020

Will you get a text from your doctor? Will you read about it online? Or will you have to check the Centers for Disease Control and Prevention website to know when it's your turn in line? As COVID-19 vaccines roll out to limited groups of people across the United States, how people learn they are eligible to get their shots won't be as clear while supplies remain limited, according to public health and policy experts and state vaccination plans. "I think it's going to be a little bit murky," said Katie Greene, a visiting policy associate at the Duke-Margolis Center for Health Policy.

The Oxford-AstraZeneca Vaccine Could be a Game-Changer for Inequality

The Oxford-AstraZeneca Vaccine Could be a Game-Changer for Inequality

Barron's, December 31, 2020

Mass vaccination offers hope for a return to the prepandemic normal. But the distribution process also comes with some potentially nasty side effects: Vaccination without a careful plan could inadvertently make the world even more unequal than a year ago. The two initial vaccine candidates, from Pfizer-BioNTech and Moderna, may have particularly problematic consequences for inequality. But the candidate that may have seemed like a runner-up in the vaccine race, from Oxford- AstraZeneca, has strong potential to finish as the most essential vaccine to end the pandemic.

Opinion: Looking Toward a Post-Vaccine COVID-19 America

Opinion: Looking Toward a Post-Vaccine COVID-19 America

The Detroit News, December 27, 2020

Immunization of health-care workers and residents of long-term care facilities has begun.  With each day bringing over 250,000 new confirmed cases and well over 2,000 additional deaths in the U.S., help is on the way to curb the COVID-19 momentum plaguing our nation. The full benefits of the vaccine will not be realized until tens of millions of people receive their two-dose regimen, which will likely not occur until the summer of 2021.  

Collaboration, Not Competition, Will Lead to More COVID-19 Vaccine Options

Collaboration, Not Competition, Will Lead to More COVID-19 Vaccine Options

The Washington Times, December 24, 2020

The U.S. Food and Drug Administration (FDA) has approved two COVID-19 vaccines under the Emergency Use Authorization (EUA) process. With these approvals, the immunization of health care workers and those in long-term care facilities has begun, providing them with a measure of protection against COVID-19. Waiting in the immunization queue are essential workers and at-risk populations. The expectation is that vaccines will be available for all who wish to be immunized by the middle of 2021.

Are You Eligible for a COVID-19 Vaccine? Washington State to Launch Tool, Rely on Honor System

Are You Eligible for a COVID-19 Vaccine? Washington State to Launch Tool, Rely on Honor System

The Seattle Times, December 31, 2020

Washington state will rely on an honor system to determine eligibility for COVID-19 vaccinations, so those administering vaccines do not have to police who qualifies. The state plans to launch an online questionnaire — called PhaseFinder — soon where people can determine their own eligibility for vaccination. When more vaccination sites are available, members of the public could present screenshots of their questionnaire results at vaccination sites, said Mary Huynh, a deputy director at the state Department of Health. The state also plans to provide a template letter for employers to vouch for workers’ eligibility.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine